跳至主要内容
临床试验/NCT07095634
NCT07095634Enrolling By Invitation不适用

Protocollo Sulla Valutazione Del RischiO cardioVAscolare Nel Crohn e ColIte Ulcerosa (PROVACI). Estimation of Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis

IRCCS Policlinico S. Donato1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2025年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
600
试验地点
1
主要终点
Occurrence of Major cardiovascular events

研究概览

简要总结

Inflammatory bowel diseases (IBD) are progressively increasing their prevalence worldwide. Up to half of patients may also have extraintestinal manifestation and cardiovascular diseases (CVDs) is one of the most relevant, being the second cause of death in these patients. The classical cardiovascular (CV) risk scores do not adquately capture the CV risk in IBD.

We are planning a prospective observational study to evaluate patients with IBD and a gender/age-matched cohort with the aims to investigate in 2-years follow-up

  • Occurrence of major cardiovascular events (MACEs) in both cohorts;
  • Predictive factors of risk for MACEs in IBD compared to controls;
  • Multi-omics evaluations with the support of artificial intelligence of biomarkers associated with occurrence of MACEs in IBD

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with confrimed diagnosis of Crohn's disease and Ulcerative colitis-

排除标准

  • No willing to sign the informe content and have 2 years of follow-up

结局指标

主要结局

Occurrence of Major cardiovascular events

时间窗: 2 years

Myocardial infarction, stroke, transient ischemic attack, heart failure, atrial fibrillation, acute arterial embolysm, ischemic angina

次要结局

  • Multi-omics evaluations of biomarkers in IBD patients with occurrence of MACEs(2 years follow-up)

研究者

发起方
IRCCS Policlinico S. Donato
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vito Annese

Associate Professor University Vita-Salute San Raffaele, Milan; Head of Gastroenterology IRCCS San Donato Policlinic

IRCCS Policlinico S. Donato

研究点 (1)

Loading locations...

相似试验